BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16062099)

  • 1. Levetiracetam-induced parkinsonism in a Huntington disease patient.
    Zesiewicz TA; Sanchez-Ramos J; Sullivan KL; Hauser RA
    Clin Neuropharmacol; 2005; 28(4):188-90. PubMed ID: 16062099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam-induced Parkinsonism in a Huntington disease patient.
    Gatto EM; Roca CU; Etcheverry JL; Fadel D
    Clin Neuropharmacol; 2006; 29(6):303-4. PubMed ID: 17095892
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical characteristics of neuroleptic-induced parkinsonism.
    Hassin-Baer S; Sirota P; Korczyn AD; Treves TA; Epstein B; Shabtai H; Martin T; Litvinjuk Y; Giladi N
    J Neural Transm (Vienna); 2001; 108(11):1299-308. PubMed ID: 11768628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
    Zesiewicz TA; Sullivan KL; Hauser RA; Sanchez-Ramos J
    Mov Disord; 2006 Nov; 21(11):1998-2001. PubMed ID: 16941461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of cluster headache effectively treated with levetiracetam.
    Palermo A; Giglia G; Cosentino G; Raieli V; Brighina F; Fierro B
    Funct Neurol; 2013; 28(1):63-4. PubMed ID: 23731917
    [No Abstract]   [Full Text] [Related]  

  • 6. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type.
    Kyomen HH; Whitfield TH; Baldessarini RJ
    J Clin Psychopharmacol; 2007 Aug; 27(4):408-10. PubMed ID: 17632234
    [No Abstract]   [Full Text] [Related]  

  • 7. A New Alternative Drug With Fewer Adverse Effects in the Treatment of Sydenham Chorea: Levetiracetam Efficacy in a Child.
    Şahin S; Cansu A
    Clin Neuropharmacol; 2015; 38(4):144-6. PubMed ID: 26166232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.
    McSwain ML; Forman LM
    J Clin Psychopharmacol; 1995 Aug; 15(4):284. PubMed ID: 7593712
    [No Abstract]   [Full Text] [Related]  

  • 9. Levetiracetam for agitated Alzheimer's disease patients.
    Weiner MF; Womack KB; Martin-Cook K; Svetlik DA; Hynan LS
    Int Psychogeriatr; 2005 Jun; 17(2):327-8. PubMed ID: 16050441
    [No Abstract]   [Full Text] [Related]  

  • 10. Levetiracetam for the treatment of status epilepticus.
    Zheng F; Du C; Wang X
    Expert Rev Neurother; 2015 Oct; 15(10):1113-21. PubMed ID: 26416394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-pharmacological treatments in a patient with dementia due to Huntington's disease.
    Lee HM; Chen ST; Chen SJ
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E17. PubMed ID: 20463131
    [No Abstract]   [Full Text] [Related]  

  • 12. Dramatic response to levetiracetam in post-ischaemic Holmes' tremor.
    Striano P; Elefante A; Coppola A; Tortora F; Zara F; Minetti C; Striano S
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):438-9. PubMed ID: 17369598
    [No Abstract]   [Full Text] [Related]  

  • 13. Levetiracetam in tardive dyskinesia: an open label study.
    Konitsiotis S; Pappa S; Mantas C; Mavreas V
    Mov Disord; 2006 Aug; 21(8):1219-21. PubMed ID: 16637037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam for the treatment of hot flashes: a phase II study.
    Thompson S; Bardia A; Tan A; Barton DL; Kottschade L; Sloan JA; Christensen B; Smith D; Loprinzi CL
    Support Care Cancer; 2008 Jan; 16(1):75-82. PubMed ID: 17598133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catatonia induced by levetiracetam.
    Chouinard MJ; Nguyen DK; Clément JF; Bruneau MA
    Epilepsy Behav; 2006 Feb; 8(1):303-7. PubMed ID: 16249124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia.
    Löscher W; Richter A
    Eur J Pharmacol; 2000 Mar; 391(3):251-4. PubMed ID: 10729365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced psychosis after long-term treatment with levetiracetam.
    Bayerlein K; Frieling H; Beyer B; Kornhuber J; Bleich S
    Can J Psychiatry; 2004 Dec; 49(12):868. PubMed ID: 15679219
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of pharmacoresistent continuous spike wave activity during slow sleep with levetiracetam.
    Hoppen T; Sandrieser T; Rister M
    Eur J Pediatr; 2003 Jan; 162(1):59-61. PubMed ID: 12607537
    [No Abstract]   [Full Text] [Related]  

  • 19. Chorea in a patient with cerebral palsy: treatment with levetiracetam.
    Recio MV; Hauser RA; Louis ED; Radhashakar H; Sullivan KL; Zesiewicz TA
    Mov Disord; 2005 Jun; 20(6):762-4. PubMed ID: 15747368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of piracetam on involuntary movements in Huntington's disease. A double-blind, placebo-controlled study].
    Mateo D; Giménez-Roldán S
    Neurologia; 1996 Jan; 11(1):16-9. PubMed ID: 8714171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.